ConductScience.org, home

Paper34066917

Ixekizumab May Improve Renal Function in Psoriasis.

Amoruso GF and 6 others. Healthcare (Basel), 2021. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Ixekizumab May Improve Renal Function in Psoriasis. Papers, record 34066917. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34066917

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ixekizumab May Improve Renal Function in Psoriasis.
PubMed
Journal
Healthcare (Basel)
PubMed
Year
2021
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
2.53
iCite
Revised in PubMed
2021-06-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Amoruso GFGiuseppe Fabrizio
2Nisticò SPSteven Paul
3Iannone LLuigi
4Russo EEmilio
5Rago GGiuseppe
6Patruno CCataldohttps://orcid.org/0000-0001-8661-2822
7Bennardo LLuigihttps://orcid.org/0000-0002-0434-1027

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133141869Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study.PLoS One2020https://conductscience.org/library/papers/33141869PubMed
229140820Renal effects of cytokines in hypertension.Curr Opin Nephrol Hypertens2018https://conductscience.org/library/papers/29140820PubMed
333383665Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis.J Pers Med2020https://conductscience.org/library/papers/33383665PubMed
419820122Th1 and Th17 cells induce proliferative glomerulonephritis.J Am Soc Nephrol2009https://conductscience.org/library/papers/19820122PubMed
525292347Effect of anti-tumor necrosis factor alpha treatment of rheumatoid arthritis and chronic kidney disease.Rheumatol Int2015https://conductscience.org/library/papers/25292347PubMed
630295379Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.Dermatol Ther2018https://conductscience.org/library/papers/30295379PubMed
733141505Emerging role of anti-IL23 in the treatment of psoriasis: When humanized is very promising.Dermatol Ther2020https://conductscience.org/library/papers/33141505PubMed
826949177Biologics for the treatment of autoimmune renal diseases.Nat Rev Nephrol2016https://conductscience.org/library/papers/26949177PubMed
931694234Topical and Oral Therapies for Childhood Atopic Dermatitis and Plaque Psoriasis.Children (Basel)2019https://conductscience.org/library/papers/31694234PubMed
1032942670Methotrexate and Adalimumab Decrease the Serum Levels of Cardiovascular Disease Biomarkers (VCAM-1 and E-Selectin) in Plaque Psoriasis.Medicina (Kaunas)2020https://conductscience.org/library/papers/32942670PubMed
1131762153Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report.Dermatol Ther2020https://conductscience.org/library/papers/31762153PubMed
1230733983An interleukin-17 inhibitor successfully treated a complicated psoriasis and psoriatic arthritis patient with hepatitis B virus infection and end-stage kidney disease on hemodialysis.JAAD Case Rep2019https://conductscience.org/library/papers/30733983PubMed
1333419370Pharmacogenetics Update on Biologic Therapy in Psoriasis.Medicina (Kaunas)2020https://conductscience.org/library/papers/33419370PubMed
1420100727Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis.Nephrol Dial Transplant2010https://conductscience.org/library/papers/20100727PubMed
1533050592New Treatment Addressing the Pathogenesis of Psoriasis.Int J Mol Sci2020https://conductscience.org/library/papers/33050592PubMed
1625887118IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment.BMC Immunol2015https://conductscience.org/library/papers/25887118PubMed
1731572188Interleukin 17A Participates in Renal Inflammation Associated to Experimental and Human Hypertension.Front Pharmacol2019https://conductscience.org/library/papers/31572188PubMed
1831881298Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease.J Am Acad Dermatol2020https://conductscience.org/library/papers/31881298PubMed
1933066228Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33066228PubMed
2031963845Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?J Clin Med2020https://conductscience.org/library/papers/31963845PubMed

See all 28 referencesDownload CSV of references

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
40285915Vildagliptin topical ointment: an effective treatment for imiquimod-induced psoriasis in mice.J Mol Histol2025https://conductscience.org/library/papers/40285915PubMed
39254877The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39254877PubMed
35888704Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis-Preliminary Data.Metabolites2022https://conductscience.org/library/papers/35888704PubMed
35682382Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks.Int J Environ Res Public Health2022https://conductscience.org/library/papers/35682382PubMed
35629363Dextromethorphan Exhibits Anti-Inflammatory and Immunomodulatory Effects in a Murine Model: Therapeutic Implication in Psoriasis.Life (Basel)2022https://conductscience.org/library/papers/35629363PubMed
35625795Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center.Biomedicines2022https://conductscience.org/library/papers/35625795PubMed
35563374Transcriptomic Profiling of Peripheral Edge of Lesions to Elucidate the Pathogenesis of Psoriasis Vulgaris.Int J Mol Sci2022https://conductscience.org/library/papers/35563374PubMed
35456720Anti-Psoriasis Effect of Diclofenac and Celecoxib Using the Tail Model for Psoriasis.Pharmaceutics2022https://conductscience.org/library/papers/35456720PubMed
35407618Degenerative and Inflammatory Osteoproliferations in Lumbar Radiographs in Psoriatic Arthritis Patients.J Clin Med2022https://conductscience.org/library/papers/35407618PubMed
35268344Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of Life.J Clin Med2022https://conductscience.org/library/papers/35268344PubMed
35214027Colchicine in Managing Skin Conditions: A Systematic Review.Pharmaceutics2022https://conductscience.org/library/papers/35214027PubMed
35163233The Role of Podoplanin in Skin Diseases.Int J Mol Sci2022https://conductscience.org/library/papers/35163233PubMed
35054504Transcriptional Analysis-Based Alterations Affecting Neuritogenesis of the Peripheral Nervous System in Psoriasis.Life (Basel)2022https://conductscience.org/library/papers/35054504PubMed
34945136Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.J Clin Med2021https://conductscience.org/library/papers/34945136PubMed
34834393Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management.Pharmaceutics2021https://conductscience.org/library/papers/34834393PubMed
34827121Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus-Preliminary Data.Biology (Basel)2021https://conductscience.org/library/papers/34827121PubMed
34638740Psoriasis and Atherosclerosis-Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics.Int J Mol Sci2021https://conductscience.org/library/papers/34638740PubMed
34571998Compositional Features of Distinct Microbiota Base on Serum Extracellular Vesicle Metagenomics Analysis in Moderate to Severe Psoriasis Patients.Cells2021https://conductscience.org/library/papers/34571998PubMed
34502197The Role of Epigenetic Factors in Psoriasis.Int J Mol Sci2021https://conductscience.org/library/papers/34502197PubMed
34442396The Impact of Smoking on Psoriasis Patients with Biological Therapies in a Bucharest Hospital.J Pers Med2021https://conductscience.org/library/papers/34442396PubMed

See all 25 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL17A3605PubTator's text mininghttps://conductscience.org/library/genes/3605NCBI Gene
IL17F112744PubTator's text mininghttps://conductscience.org/library/genes/112744NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
IL23A51561PubTator's text mininghttps://conductscience.org/library/genes/51561NCBI Gene
SLC17A526503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34066917

GET https://conductscience.org/api/papers/v1/34066917/references?page=2